Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression. - Burke CM; Feinberg TY; Brosius S; Bhanot UK; Jain M; Linkov I; Siddiquee A; Guillan K; Ibáñez G; Ndengu AA; Calder P; Rosales N; et al. (Molecular cancer therapeutics, 2026)